| |
Newsroom /
Medical
/
Medical
/
Electrophysiology Devices
Electrophysiology Devices 
The Global Electrophysiology Devices Market is Expected to Grow at a CAGR of 10% over the 2009 – 2016 Period.
Hyderabad,
AP,
India
(prbd.net)
26/08/2010
"Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016"
The global electrophysiology devices market was valued at about $1.7 billion in 2009, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 10% over the years 2009–2016, to reach $3.4 billion in 2016. The market is categorised into three segments: laboratory systems, ablation catheters, and diagnostic catheters. The largest segment in terms of revenue generation is the diagnostic catheters segment, which had a market size of $917m in 2009. This segment is expected to grow at a CAGR of 11% over the years 2009 – 2016, to reach revenues of $1.9 billion in the 2016.
The major geographical market for electrophysiology devices is the US with revenues of $625m in 2009. Contribution of US towards global electrophysiology devices market for is expected to increase from 37% in 2009 to 40% in 2016. The growth in US market is attributed to rising patient population. In the US, about 2.3 million people in 2009 were diagnosed with atrial fibrillation.
For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Electrophysiology-Devices--Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices
The rising prevalence of Atrial Fibrillation (AF) is expected to drive the growth in the electrophysiology devices market. In 2009, about 2.3 million people in the US and 4.6 million in Europe were diagnosed with AF. The number of patients with AF is expected to be about 10 million globally.
The prevalence of AF rises with increasing age. The prevalence is about 0.1% in age group of 55 – 60, 3.8% in age group of 60 – 79 and 10% in age group of 80 and above. The global ageing would lead to rise in AF patient population. In the current scenario, where there is no permanent treatment for AF, ablations offer the best choice of treatment, providing strong potential for the electrophysiology devices market growth.
In 2009, Biosense Webster, and St.Jude Medical were the leading players in the global electrophysiology devices market with a combined share of 63%. Biosense Webster with a share of 34% was the leader followed by St. Jude with a 29% share in the global electrophysiology devices market.
GlobalData’s new report, “Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global electrophysiology devices market. The report provides market landscape, competitive landscape and market trends information the electrophysiology devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Electrophysiology-Devices--Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices
Visit our report store: http://www.globaldata.com
For more details Contact:
pressreleases@globaldata.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GlobalData is a global market intelligence services company providing information research and analysis products and services.
|